ID   ACTN2_HUMAN             Reviewed;         894 AA.
AC   P35609; B1ANE4; B2RCS5; Q86TF4; Q86TI8;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   22-JUL-2015, entry version 174.
DE   RecName: Full=Alpha-actinin-2;
DE   AltName: Full=Alpha-actinin skeletal muscle isoform 2;
DE   AltName: Full=F-actin cross-linking protein;
GN   Name=ACTN2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RC   TISSUE=Skeletal muscle;
RX   PubMed=1339456;
RA   Beggs A.H., Byers T.J., Knoll J.H.M., Boyce F.M., Bruns G.A.P.,
RA   Kunkel L.M.;
RT   "Cloning and characterization of two human skeletal muscle alpha-
RT   actinin genes located on chromosomes 1 and 11.";
RL   J. Biol. Chem. 267:9281-9288(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10548523; DOI=10.1006/bbrc.1999.1661;
RA   Tiso N., Majetti M., Stanchi F., Rampazzo A., Zimbello R., Nava A.,
RA   Danieli G.A.;
RT   "Fine mapping and genomic structure of ACTN2, the human gene coding
RT   for the sarcomeric isoform of alpha-actinin-2, expressed in skeletal
RT   and cardiac muscle.";
RL   Biochem. Biophys. Res. Commun. 265:256-259(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH LDB3.
RX   PubMed=10427098; DOI=10.1083/jcb.146.2.465;
RA   Faulkner G., Pallavicini A., Formentin E., Comelli A., Ievolella C.,
RA   Trevisan S., Bortoletto G., Scannapieco P., Salamon M., Mouly V.,
RA   Valle G., Lanfranchi G.;
RT   "ZASP: a new Z-band alternatively spliced PDZ-motif protein.";
RL   J. Cell Biol. 146:465-475(1999).
RN   [8]
RP   INTERACTION WITH MYOZ1.
RX   PubMed=10984498; DOI=10.1074/jbc.M007493200;
RA   Faulkner G., Pallavicini A., Comelli A., Salamon M., Bortoletto G.,
RA   Ievolella C., Trevisan S., Kojic' S., Dalla Vecchia F., Laveder P.,
RA   Valle G., Lanfranchi G.;
RT   "FATZ, a filamin-, actinin-, and telethonin-binding protein of the Z-
RT   disc of skeletal muscle.";
RL   J. Biol. Chem. 275:41234-41242(2000).
RN   [9]
RP   INTERACTION WITH MYOZ1 AND MYOZ2.
RX   PubMed=11114196; DOI=10.1073/pnas.260501097;
RA   Frey N., Richardson J.A., Olson E.N.;
RT   "Calsarcins, a novel family of sarcomeric calcineurin-binding
RT   proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:14632-14637(2000).
RN   [10]
RP   INTERACTION WITH MYOZ1, AND SUBCELLULAR LOCATION.
RX   PubMed=11171996; DOI=10.1073/pnas.98.4.1595;
RA   Takada F., Vander Woude D.L., Tong H.-Q., Thompson T.G., Watkins S.C.,
RA   Kunkel L.M., Beggs A.H.;
RT   "Myozenin: an alpha-actinin- and gamma-filamin-binding protein of
RT   skeletal muscle Z lines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:1595-1600(2001).
RN   [11]
RP   INTERACTION WITH MYOZ3.
RX   PubMed=11842093; DOI=10.1074/jbc.M200712200;
RA   Frey N., Olson E.N.;
RT   "Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin
RT   family, interacts with multiple Z-disc proteins.";
RL   J. Biol. Chem. 277:13998-14004(2002).
RN   [12]
RP   INTERACTION WITH PARVB.
RX   PubMed=15159419; DOI=10.1083/jcb.200308141;
RA   Yamaji S., Suzuki A., Kanamori H., Mishima W., Yoshimi R.,
RA   Takasaki H., Takabayashi M., Fujimaki K., Fujisawa S., Ohno S.,
RA   Ishigatsubo Y.;
RT   "Affixin interacts with alpha-actinin and mediates integrin signaling
RT   for reorganization of F-actin induced by initial cell-substrate
RT   interaction.";
RL   J. Cell Biol. 165:539-551(2004).
RN   [13]
RP   INTERACTION WITH XIRP2.
RX   PubMed=17046827; DOI=10.1074/jbc.M603244200;
RA   Huang H.-T., Brand O.M., Mathew M., Ignatiou C., Ewen E.P.,
RA   McCalmon S.A., Naya F.J.;
RT   "Myomaxin is a novel transcriptional target of MEF2A that encodes a
RT   Xin-related alpha-actinin-interacting protein.";
RL   J. Biol. Chem. 281:39370-39379(2006).
RN   [14]
RP   INTERACTION WITH DST, AND SUBCELLULAR LOCATION.
RX   PubMed=19932097; DOI=10.1016/j.yexcr.2009.11.010;
RA   Steiner-Champliaud M.F., Schneider Y., Favre B., Paulhe F.,
RA   Praetzel-Wunder S., Faulkner G., Konieczny P., Raith M., Wiche G.,
RA   Adebola A., Liem R.K., Langbein L., Sonnenberg A., Fontao L.,
RA   Borradori L.;
RT   "BPAG1 isoform-b: complex distribution pattern in striated and heart
RT   muscle and association with plectin and alpha-actinin.";
RL   Exp. Cell Res. 316:297-313(2010).
RN   [15]
RP   UBIQUITINATION BY FBXL22.
RX   PubMed=22972877; DOI=10.1161/CIRCRESAHA.112.271007;
RA   Spaich S., Will R.D., Just S., Spaich S., Kuhn C., Frank D.,
RA   Berger I.M., Wiemann S., Korn B., Koegl M., Backs J., Katus H.A.,
RA   Rottbauer W., Frey N.;
RT   "F-box and leucine-rich repeat protein 22 is a cardiac-enriched F-box
RT   protein that regulates sarcomeric protein turnover and is essential
RT   for maintenance of contractile function in vivo.";
RL   Circ. Res. 111:1504-1516(2012).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 391-637.
RX   PubMed=10481917; DOI=10.1016/S0092-8674(00)81981-9;
RA   Djinovic-Carugo K., Young P., Gautel M., Saraste M.;
RT   "Structure of the alpha-actinin rod: molecular basis for cross-linking
RT   of actin filaments.";
RL   Cell 98:537-546(1999).
RN   [17]
RP   STRUCTURE BY NMR OF 823-894 IN COMPLEX WITH A TITIN Z-REPEAT.
RX   PubMed=11573089; DOI=10.1038/nsb1001-853;
RA   Atkinson R.A., Joseph C., Kelly G., Muskett F.W., Frenkiel T.A.,
RA   Nietlispach D., Pastore A.;
RT   "Ca2+-independent binding of an EF-hand domain to a novel motif in the
RT   alpha-actinin-titin complex.";
RL   Nat. Struct. Biol. 8:853-857(2001).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 274-746.
RX   PubMed=11470434; DOI=10.1016/S0969-2126(01)00619-0;
RA   Ylanne J., Scheffzek K., Young P., Saraste M.;
RT   "Crystal structure of the alpha-actinin rod reveals an extensive
RT   torsional twist.";
RL   Structure 9:597-604(2001).
RN   [19]
RP   VARIANT CMD1AA ARG-9, AND VARIANT VAL-604.
RX   PubMed=14567970; DOI=10.1016/S1096-7192(03)00142-2;
RA   Mohapatra B., Jimenez S., Lin J.H., Bowles K.R., Coveler K.J.,
RA   Marx J.G., Chrisco M.A., Murphy R.T., Lurie P.R., Schwartz R.J.,
RA   Elliott P.M., Vatta M., McKenna W., Towbin J.A., Bowles N.E.;
RT   "Mutations in the muscle LIM protein and alpha-actinin-2 genes in
RT   dilated cardiomyopathy and endocardial fibroelastosis.";
RL   Mol. Genet. Metab. 80:207-215(2003).
RN   [20]
RP   VARIANTS CMH THR-119; MET-495; ALA-583 AND GLY-628.
RX   PubMed=20022194; DOI=10.1016/j.jacc.2009.11.016;
RA   Chiu C., Bagnall R.D., Ingles J., Yeates L., Kennerson M.,
RA   Donald J.A., Jormakka M., Lind J.M., Semsarian C.;
RT   "Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy: a
RT   genome-wide analysis.";
RL   J. Am. Coll. Cardiol. 55:1127-1135(2010).
CC   -!- FUNCTION: F-actin cross-linking protein which is thought to anchor
CC       actin to a variety of intracellular structures. This is a bundling
CC       protein.
CC   -!- SUBUNIT: Homodimer; antiparallel. Also forms heterodimers with
CC       ACTN3. Interacts with ADAM12, MYOZ1, MYOZ2 and MYOZ3. Interacts
CC       via its C-terminal region with the LDB3 PDZ domain. Interacts with
CC       XIRP2. Interacts with DST isoform 1 (via N-terminus). Interacts
CC       with PARVB. {ECO:0000269|PubMed:10427098,
CC       ECO:0000269|PubMed:10984498, ECO:0000269|PubMed:11114196,
CC       ECO:0000269|PubMed:11171996, ECO:0000269|PubMed:11842093,
CC       ECO:0000269|PubMed:15159419, ECO:0000269|PubMed:17046827,
CC       ECO:0000269|PubMed:19932097}.
CC   -!- INTERACTION:
CC       Self; NbExp=9; IntAct=EBI-77797, EBI-77797;
CC       Q61824:Adam12 (xeno); NbExp=3; IntAct=EBI-77797, EBI-77785;
CC       P03950:ANG; NbExp=4; IntAct=EBI-77797, EBI-525291;
CC       Q9UKG1:APPL1; NbExp=2; IntAct=EBI-77797, EBI-741243;
CC       Q5PSV4:BRMS1L; NbExp=3; IntAct=EBI-77797, EBI-5666615;
CC       A8K880:C9orf138; NbExp=3; IntAct=EBI-77797, EBI-10174528;
CC       Q9NRI5:DISC1; NbExp=3; IntAct=EBI-77797, EBI-529989;
CC       O75923:DYSF; NbExp=2; IntAct=EBI-77797, EBI-2799016;
CC       P22460:KCNA5; NbExp=6; IntAct=EBI-77797, EBI-6426121;
CC       Q8IY33:MICALL2; NbExp=3; IntAct=EBI-77797, EBI-2555563;
CC       P00540:MOS; NbExp=3; IntAct=EBI-77797, EBI-1757866;
CC       P54296:MYOM2; NbExp=2; IntAct=EBI-77797, EBI-5357134;
CC       Q9NPC6:MYOZ2; NbExp=6; IntAct=EBI-77797, EBI-746712;
CC       Q53GG5:PDLIM3; NbExp=4; IntAct=EBI-77797, EBI-5658852;
CC       Q14D33:RTP5; NbExp=3; IntAct=EBI-77797, EBI-10217913;
CC       O95863:SNAI1; NbExp=3; IntAct=EBI-77797, EBI-1045459;
CC       P23497:SP100; NbExp=5; IntAct=EBI-77797, EBI-751145;
CC       Q8WZ42:TTN; NbExp=16; IntAct=EBI-77797, EBI-681210;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, myofibril, sarcomere, Z line
CC       {ECO:0000269|PubMed:11171996, ECO:0000269|PubMed:19932097}.
CC       Note=Colocalizes with MYOZ1 and FLNC at the Z-lines of skeletal
CC       muscle.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P35609-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P35609-2; Sequence=VSP_054923;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in both skeletal and cardiac muscle.
CC   -!- PTM: Ubiquitinated by FBXL22, leading to proteasomal degradation.
CC       {ECO:0000269|PubMed:22972877}.
CC   -!- DISEASE: Cardiomyopathy, familial hypertrophic (CMH) [MIM:192600]:
CC       A hereditary heart disorder characterized by ventricular
CC       hypertrophy, which is usually asymmetric and often involves the
CC       interventricular septum. The symptoms include dyspnea, syncope,
CC       collapse, palpitations, and chest pain. They can be readily
CC       provoked by exercise. The disorder has inter- and intrafamilial
CC       variability ranging from benign to malignant forms with high risk
CC       of cardiac failure and sudden cardiac death.
CC       {ECO:0000269|PubMed:20022194}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Cardiomyopathy, dilated 1AA (CMD1AA) [MIM:612158]: A
CC       disorder characterized by ventricular dilation and impaired
CC       systolic function, resulting in congestive heart failure and
CC       arrhythmia. Patients are at risk of premature death.
CC       {ECO:0000269|PubMed:14567970}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the alpha-actinin family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 actin-binding domain. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 2 CH (calponin-homology) domains.
CC       {ECO:0000255|PROSITE-ProRule:PRU00044}.
CC   -!- SIMILARITY: Contains 2 EF-hand domains. {ECO:0000255|PROSITE-
CC       ProRule:PRU00448}.
CC   -!- SIMILARITY: Contains 4 spectrin repeats. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M86406; AAA51583.1; -; mRNA.
DR   EMBL; M86804; AAA51584.1; -; Genomic_DNA.
DR   EMBL; AJ249756; CAB61269.1; -; Genomic_DNA.
DR   EMBL; AJ249757; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249758; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249759; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249760; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249761; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249762; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249763; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249764; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249765; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249766; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249767; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249768; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249769; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249770; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249771; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249772; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249773; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249774; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249775; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AJ249776; CAB61269.1; JOINED; Genomic_DNA.
DR   EMBL; AK315250; BAG37672.1; -; mRNA.
DR   EMBL; AL359185; CAH73201.1; -; Genomic_DNA.
DR   EMBL; AL359921; CAH73201.1; JOINED; Genomic_DNA.
DR   EMBL; AL359921; CAI13778.1; -; Genomic_DNA.
DR   EMBL; AL359185; CAI13778.1; JOINED; Genomic_DNA.
DR   EMBL; CH471098; EAW70064.1; -; Genomic_DNA.
DR   EMBL; CH471098; EAW70065.1; -; Genomic_DNA.
DR   EMBL; BC047901; AAH47901.2; -; mRNA.
DR   EMBL; BC051770; AAH51770.2; -; mRNA.
DR   CCDS; CCDS1613.1; -. [P35609-1]
DR   CCDS; CCDS60455.1; -. [P35609-2]
DR   PIR; A40199; FAHUA2.
DR   RefSeq; NP_001094.1; NM_001103.3. [P35609-1]
DR   RefSeq; NP_001265272.1; NM_001278343.1. [P35609-2]
DR   RefSeq; NP_001265273.1; NM_001278344.1.
DR   UniGene; Hs.498178; -.
DR   PDB; 1H8B; NMR; -; A=822-894.
DR   PDB; 1HCI; X-ray; 2.80 A; A/B=274-746.
DR   PDB; 1QUU; X-ray; 2.50 A; A=391-637.
DR   PDB; 4D1E; X-ray; 3.50 A; A=19-894.
DR   PDBsum; 1H8B; -.
DR   PDBsum; 1HCI; -.
DR   PDBsum; 1QUU; -.
DR   PDBsum; 4D1E; -.
DR   ProteinModelPortal; P35609; -.
DR   SMR; P35609; 34-894.
DR   BioGrid; 106603; 47.
DR   DIP; DIP-383N; -.
DR   IntAct; P35609; 38.
DR   MINT; MINT-145583; -.
DR   STRING; 9606.ENSP00000355537; -.
DR   PhosphoSite; P35609; -.
DR   DMDM; 543742; -.
DR   MaxQB; P35609; -.
DR   PaxDb; P35609; -.
DR   PeptideAtlas; P35609; -.
DR   PRIDE; P35609; -.
DR   Ensembl; ENST00000366578; ENSP00000355537; ENSG00000077522.
DR   Ensembl; ENST00000542672; ENSP00000443495; ENSG00000077522. [P35609-2]
DR   GeneID; 88; -.
DR   KEGG; hsa:88; -.
DR   UCSC; uc001hyf.2; human. [P35609-1]
DR   UCSC; uc009xgi.1; human.
DR   CTD; 88; -.
DR   GeneCards; GC01P236849; -.
DR   GeneReviews; ACTN2; -.
DR   HGNC; HGNC:164; ACTN2.
DR   HPA; HPA006035; -.
DR   HPA; HPA008315; -.
DR   MIM; 102573; gene.
DR   MIM; 192600; phenotype.
DR   MIM; 612158; phenotype.
DR   neXtProt; NX_P35609; -.
DR   Orphanet; 154; Familial isolated dilated cardiomyopathy.
DR   PharmGKB; PA25; -.
DR   eggNOG; COG5069; -.
DR   GeneTree; ENSGT00760000118813; -.
DR   HOGENOM; HOG000263418; -.
DR   HOVERGEN; HBG050453; -.
DR   InParanoid; P35609; -.
DR   KO; K05699; -.
DR   OMA; RAKWDKV; -.
DR   OrthoDB; EOG72C4ZJ; -.
DR   PhylomeDB; P35609; -.
DR   TreeFam; TF352676; -.
DR   Reactome; REACT_16969; Striated Muscle Contraction.
DR   Reactome; REACT_20546; Ras activation uopn Ca2+ infux through NMDA receptor.
DR   Reactome; REACT_20594; Unblocking of NMDA receptor, glutamate binding and activation.
DR   Reactome; REACT_20642; CREB phosphorylation through the activation of CaMKII.
DR   Reactome; REACT_23832; Nephrin interactions.
DR   Reactome; REACT_318; Platelet degranulation.
DR   ChiTaRS; ACTN2; human.
DR   EvolutionaryTrace; P35609; -.
DR   GeneWiki; Actinin,_alpha_2; -.
DR   GenomeRNAi; 88; -.
DR   NextBio; 327; -.
DR   PRO; PR:P35609; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; P35609; -.
DR   CleanEx; HS_ACTN2; -.
DR   ExpressionAtlas; P35609; baseline and differential.
DR   Genevisible; P35609; HS.
DR   GO; GO:0005884; C:actin filament; TAS:ProtInc.
DR   GO; GO:0030864; C:cortical actin cytoskeleton; IEA:Ensembl.
DR   GO; GO:0005856; C:cytoskeleton; NAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0043197; C:dendritic spine; TAS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0030175; C:filopodium; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IMP:UniProtKB.
DR   GO; GO:0031093; C:platelet alpha granule lumen; TAS:Reactome.
DR   GO; GO:0031143; C:pseudopodium; TAS:UniProtKB.
DR   GO; GO:0030018; C:Z disc; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IDA:UniProtKB.
DR   GO; GO:0051373; F:FATZ binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005178; F:integrin binding; TAS:UniProtKB.
DR   GO; GO:0044325; F:ion channel binding; IPI:UniProtKB.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; IDA:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IMP:UniProtKB.
DR   GO; GO:0008307; F:structural constituent of muscle; TAS:ProtInc.
DR   GO; GO:0030375; F:thyroid hormone receptor coactivator activity; IEA:Ensembl.
DR   GO; GO:0031432; F:titin binding; IPI:BHF-UCL.
DR   GO; GO:0070080; F:titin Z domain binding; IMP:UniProtKB.
DR   GO; GO:0051695; P:actin filament uncapping; IMP:UniProtKB.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0007155; P:cell adhesion; TAS:UniProtKB.
DR   GO; GO:0090002; P:establishment of protein localization to plasma membrane; IMP:UniProtKB.
DR   GO; GO:0048041; P:focal adhesion assembly; IMP:UniProtKB.
DR   GO; GO:0030035; P:microspike assembly; IDA:UniProtKB.
DR   GO; GO:0030049; P:muscle filament sliding; TAS:Reactome.
DR   GO; GO:1901017; P:negative regulation of potassium ion transmembrane transporter activity; IMP:BHF-UCL.
DR   GO; GO:0043267; P:negative regulation of potassium ion transport; IMP:BHF-UCL.
DR   GO; GO:2000009; P:negative regulation of protein localization to cell surface; IMP:BHF-UCL.
DR   GO; GO:0086097; P:phospholipase C-activating angiotensin-activated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0002576; P:platelet degranulation; TAS:Reactome.
DR   GO; GO:2001259; P:positive regulation of cation channel activity; IMP:UniProtKB.
DR   GO; GO:2001137; P:positive regulation of endocytic recycling; IMP:UniProtKB.
DR   GO; GO:1901018; P:positive regulation of potassium ion transmembrane transporter activity; IDA:BHF-UCL.
DR   GO; GO:0043268; P:positive regulation of potassium ion transport; IDA:BHF-UCL.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptotic process; NAS:UniProtKB.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:BHF-UCL.
DR   GO; GO:0045214; P:sarcomere organization; IMP:UniProtKB.
DR   GO; GO:0007268; P:synaptic transmission; TAS:Reactome.
DR   Gene3D; 1.10.238.10; -; 2.
DR   Gene3D; 1.10.418.10; -; 2.
DR   InterPro; IPR001589; Actinin_actin-bd_CS.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR014837; EF-hand_Ca_insen.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR018159; Spectrin/alpha-actinin.
DR   InterPro; IPR002017; Spectrin_repeat.
DR   Pfam; PF00307; CH; 2.
DR   Pfam; PF08726; EFhand_Ca_insen; 1.
DR   Pfam; PF00435; Spectrin; 4.
DR   SMART; SM00033; CH; 2.
DR   SMART; SM00054; EFh; 2.
DR   SMART; SM00150; SPEC; 3.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS00019; ACTININ_1; 1.
DR   PROSITE; PS00020; ACTININ_2; 1.
DR   PROSITE; PS50021; CH; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Actin-binding; Alternative splicing; Calcium;
KW   Cardiomyopathy; Complete proteome; Cytoplasm; Disease mutation;
KW   Metal-binding; Polymorphism; Reference proteome; Repeat;
KW   Ubl conjugation.
FT   CHAIN         1    894       Alpha-actinin-2.
FT                                /FTId=PRO_0000073435.
FT   DOMAIN        1    254       Actin-binding.
FT   DOMAIN       38    142       CH 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00044}.
FT   DOMAIN      151    254       CH 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00044}.
FT   REPEAT      281    391       Spectrin 1.
FT   REPEAT      401    506       Spectrin 2.
FT   REPEAT      516    627       Spectrin 3.
FT   REPEAT      637    740       Spectrin 4.
FT   DOMAIN      753    788       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      789    824       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     766    777       1; possibly ancestral.
FT   CA_BIND     802    813       2; possibly ancestral.
FT   VAR_SEQ     234    261       IVNTPKPDERAIMTYVSCFYHAFAGAEQ -> LVYTARPDE
FT                                RAIMTYVSCYYHAFAGAQK (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054923.
FT   VARIANT       9      9       Q -> R (in CMD1AA; dbSNP:rs121434525).
FT                                {ECO:0000269|PubMed:14567970}.
FT                                /FTId=VAR_054628.
FT   VARIANT     119    119       A -> T (in CMH).
FT                                {ECO:0000269|PubMed:20022194}.
FT                                /FTId=VAR_071970.
FT   VARIANT     495    495       T -> M (in CMH).
FT                                {ECO:0000269|PubMed:20022194}.
FT                                /FTId=VAR_071971.
FT   VARIANT     583    583       E -> A (in CMH).
FT                                {ECO:0000269|PubMed:20022194}.
FT                                /FTId=VAR_071972.
FT   VARIANT     604    604       M -> V (in dbSNP:rs35997569).
FT                                {ECO:0000269|PubMed:14567970}.
FT                                /FTId=VAR_033487.
FT   VARIANT     628    628       E -> G (in CMH).
FT                                {ECO:0000269|PubMed:20022194}.
FT                                /FTId=VAR_071973.
FT   HELIX        36     55       {ECO:0000244|PDB:4D1E}.
FT   HELIX        62     65       {ECO:0000244|PDB:4D1E}.
FT   HELIX        70     80       {ECO:0000244|PDB:4D1E}.
FT   HELIX        93    110       {ECO:0000244|PDB:4D1E}.
FT   HELIX       120    123       {ECO:0000244|PDB:4D1E}.
FT   HELIX       127    141       {ECO:0000244|PDB:4D1E}.
FT   TURN        142    145       {ECO:0000244|PDB:4D1E}.
FT   HELIX       153    164       {ECO:0000244|PDB:4D1E}.
FT   TURN        165    167       {ECO:0000244|PDB:4D1E}.
FT   STRAND      175    177       {ECO:0000244|PDB:4D1E}.
FT   TURN        178    182       {ECO:0000244|PDB:4D1E}.
FT   HELIX       184    193       {ECO:0000244|PDB:4D1E}.
FT   HELIX       195    197       {ECO:0000244|PDB:4D1E}.
FT   HELIX       208    220       {ECO:0000244|PDB:4D1E}.
FT   HELIX       231    236       {ECO:0000244|PDB:4D1E}.
FT   STRAND      237    239       {ECO:0000244|PDB:4D1E}.
FT   HELIX       242    256       {ECO:0000244|PDB:4D1E}.
FT   HELIX       275    294       {ECO:0000244|PDB:1HCI}.
FT   HELIX       296    303       {ECO:0000244|PDB:1HCI}.
FT   STRAND      311    313       {ECO:0000244|PDB:1HCI}.
FT   TURN        314    317       {ECO:0000244|PDB:1HCI}.
FT   HELIX       318    329       {ECO:0000244|PDB:1HCI}.
FT   HELIX       331    340       {ECO:0000244|PDB:1HCI}.
FT   TURN        341    343       {ECO:0000244|PDB:1HCI}.
FT   HELIX       344    347       {ECO:0000244|PDB:1HCI}.
FT   TURN        351    356       {ECO:0000244|PDB:1HCI}.
FT   HELIX       364    366       {ECO:0000244|PDB:1HCI}.
FT   STRAND      368    370       {ECO:0000244|PDB:1HCI}.
FT   HELIX       371    382       {ECO:0000244|PDB:1HCI}.
FT   STRAND      389    392       {ECO:0000244|PDB:4D1E}.
FT   HELIX       393    416       {ECO:0000244|PDB:1QUU}.
FT   TURN        417    419       {ECO:0000244|PDB:1QUU}.
FT   HELIX       420    425       {ECO:0000244|PDB:1QUU}.
FT   HELIX       428    430       {ECO:0000244|PDB:1HCI}.
FT   HELIX       434    470       {ECO:0000244|PDB:1QUU}.
FT   HELIX       476    536       {ECO:0000244|PDB:1QUU}.
FT   TURN        537    540       {ECO:0000244|PDB:1QUU}.
FT   TURN        548    550       {ECO:0000244|PDB:1QUU}.
FT   HELIX       551    562       {ECO:0000244|PDB:1QUU}.
FT   HELIX       564    588       {ECO:0000244|PDB:1QUU}.
FT   HELIX       604    632       {ECO:0000244|PDB:1QUU}.
FT   TURN        666    669       {ECO:0000244|PDB:1HCI}.
FT   HELIX       672    704       {ECO:0000244|PDB:1HCI}.
FT   HELIX       716    741       {ECO:0000244|PDB:1HCI}.
FT   HELIX       753    762       {ECO:0000244|PDB:4D1E}.
FT   STRAND      767    770       {ECO:0000244|PDB:4D1E}.
FT   HELIX       777    784       {ECO:0000244|PDB:4D1E}.
FT   HELIX       794    799       {ECO:0000244|PDB:4D1E}.
FT   HELIX       812    820       {ECO:0000244|PDB:4D1E}.
FT   HELIX       828    835       {ECO:0000244|PDB:4D1E}.
FT   TURN        836    840       {ECO:0000244|PDB:4D1E}.
FT   STRAND      841    843       {ECO:0000244|PDB:4D1E}.
FT   HELIX       847    853       {ECO:0000244|PDB:4D1E}.
FT   HELIX       856    865       {ECO:0000244|PDB:4D1E}.
FT   STRAND      871    873       {ECO:0000244|PDB:4D1E}.
FT   HELIX       881    888       {ECO:0000244|PDB:4D1E}.
SQ   SEQUENCE   894 AA;  103854 MW;  7F612C1C3B3E2299 CRC64;
     MNQIEPGVQY NYVYDEDEYM IQEEEWDRDL LLDPAWEKQQ RKTFTAWCNS HLRKAGTQIE
     NIEEDFRNGL KLMLLLEVIS GERLPKPDRG KMRFHKIANV NKALDYIASK GVKLVSIGAE
     EIVDGNVKMT LGMIWTIILR FAIQDISVEE TSAKEGLLLW CQRKTAPYRN VNIQNFHTSW
     KDGLGLCALI HRHRPDLIDY SKLNKDDPIG NINLAMEIAE KHLDIPKMLD AEDIVNTPKP
     DERAIMTYVS CFYHAFAGAE QAETAANRIC KVLAVNQENE RLMEEYERLA SELLEWIRRT
     IPWLENRTPE KTMQAMQKKL EDFRDYRRKH KPPKVQEKCQ LEINFNTLQT KLRISNRPAF
     MPSEGKMVSD IAGAWQRLEQ AEKGYEEWLL NEIRRLERLE HLAEKFRQKA STHETWAYGK
     EQILLQKDYE SASLTEVRAL LRKHEAFESD LAAHQDRVEQ IAAIAQELNE LDYHDAVNVN
     DRCQKICDQW DRLGTLTQKR REALERMEKL LETIDQLHLE FAKRAAPFNN WMEGAMEDLQ
     DMFIVHSIEE IQSLITAHEQ FKATLPEADG ERQSIMAIQN EVEKVIQSYN IRISSSNPYS
     TVTMDELRTK WDKVKQLVPI RDQSLQEELA RQHANERLRR QFAAQANAIG PWIQNKMEEI
     ARSSIQITGA LEDQMNQLKQ YEHNIINYKN NIDKLEGDHQ LIQEALVFDN KHTNYTMEHI
     RVGWELLLTT IARTINEVET QILTRDAKGI TQEQMNEFRA SFNHFDRRKN GLMDHEDFRA
     CLISMGYDLG EAEFARIMTL VDPNGQGTVT FQSFIDFMTR ETADTDTAEQ VIASFRILAS
     DKPYILAEEL RRELPPDQAQ YCIKRMPAYS GPGSVPGALD YAAFSSALYG ESDL
//
